No Data
No Data
Tibet cheezheng tibetan medicine (002287.SZ): in the treatment fields of the respiratory system, digestive system, and others, it has advantageous products suitable for the investment market.
On November 15, Gelonghui reported that tibet cheezheng tibetan medicine (002287.SZ) stated during a specific object investigation on November 14, 2024, that the company possesses 141 approved pharmaceutical registration numbers, covering multiple distinctive Tibetan medicine treatment areas such as orthopedics, neurology, dermatology, gynecology, pediatrics, respiratory, digestive, and cardiovascular fields; business development can discover and activate more quality products of the company, injecting new vitality into these products through precise market development strategy. A detailed business development plan has been formulated by the company for different characteristics of different products. The company has suitable products in various treatment areas such as the respiratory system and digestive system.
Qizheng Tibetan Medicine: Report for the third quarter of 2024
tibet cheezheng tibetan medicine (002287.SZ): Plans to launch employee stock ownership plan in 2024.
gelonhui September 26th | tibet cheezheng tibetan medicine (002287.SZ) announced the employee stock holding plan for 2024, the source of funds for this employee stock holding plan is the company's provision of long-term incentive fund, legal employee compensation, self-raised funds, or other ways permitted by laws and regulations. The total amount of funds for this employee stock holding plan does not exceed 156 million yuan, of which the company's provision of long-term incentive fund does not exceed 144 million yuan. The company does not provide any form of financing, guarantees, loans, or other financial assistance to shareholders. This employee stock holding plan is denominated in "shares", with each share priced at 1.00 yuan, employees
Tibet Cheezheng Tibetan Medicine: Summary of Half-Year Report in 2024.
Tibet Cheezheng Tibetan Medicine: Half-year report for the year 2024.
Tibet Cheezheng Tibetan Medicine: 2024 Half-Year Performance Bulletin